Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Benzer Materyaller

• Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
  Yazar:: Junko Takata, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-08-01)
• Differences between SSRI and SNRI in depression treatment
  Yazar:: Mateusz Grego, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)
• Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
  Yazar:: Helga Zoega, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-01-01)
• Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
  Yazar:: Patrick Pasi, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-04-01)
• Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
  Yazar:: Philippe Courtet
  Baskı/Yayın Bilgisi: (2010-08-01)